Altuntas, Y <br/><br/>
Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Nov 2003 
 - 371-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1462-8902 
<br/><br/><label>Standard No.: </label>10.1046/j.1463-1326.2003.00283.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Blood Glucose--metabolism<br/>Blood Glucose Self-Monitoring--methods<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Therapy, Combination<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--analogs & derivatives<br/>Insulin Lispro<br/>Insulin, Isophane--therapeutic use<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Postprandial Period<br/>Prospective Studies<br/>Treatment Failure